Letters to the Editor
Early introduction of mepolizumab for refractory coronary vasospasm and severe acute coronary syndrome secondary to eosinophilic granulomatosis with polyangiitis: a case report
P. Tomietto1, L. Pellin2, M. Conati3, F. Turatello4, M. Gasparotto5, G. Emmi6, M. Merlo7
- UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy. paola.tomietto@asugi.sanita.fvg.it
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Trieste, Italy.
- UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
- UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
- UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
- UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste; and Department of Medical Surgical and Health Sciences, University of Trieste, Cattinara Teaching Hospital, Trieste, Italy.
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Trieste, Italy.
CER18613
2026 Vol.44, N°4
PI 0857, PF 0858
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 42018351 [PubMed]
Received: 09/02/2025
Accepted : 05/05/2025
In Press: 22/04/2026
Published: 22/04/2026


